A comparative study of Shilajatu and Asanadi Ghana Vati in the management of Madhumeha w.s.r. to type-2 diabetes mellitus

INTRODUCTION: Diabetes mellitus is becoming an alarming problem for society nowadays causing impediment in normal life. Diabetes and its complications impose a major burden upon health-care facilities. MATERIALS AND METHODS: In this study, 90 patients of Madhumeha (type-2 diabetes mellitus) were registered and randomly divided into two groups. Out of 90 registered patients, 80 patients completed the treatment. In Group A, cap. Shilajatu (500 mg twice daily) was given for 3 months and in Group B, Asanadi Ghana Vati (2 Vati twice daily) was given for 3 months. AIM: An attempt was made to evaluate and compare the efficacy of Shilajatu and Asanadi Ghana Vati in the management of type-2 diabetes mellitus. The efficacy of therapy was assessed on the basis of improvement in sign and symptoms of diabetes mellitus, blood sugar level, and glycosylated hemoglobin RESULTS: Statistically significant improvement was observed in sign and symptoms as well as on blood sugar level in both groups after the completion of treatment. CONCLUSION: Shilajatu and Asanadi Ghana Vati seem to be effective and completely safe for the management of Madhumeha (type-2 diabetes mellitus).